Early thymic T cell development in young transgenic mice overexpressing human Cu/Zn superoxide dismutase, a model of Down syndrome

Free Radical Biology and Medicine

Volumn 40, Issue 11, 2006, Pages 1971-1980

  Laurent, Julien ^a   Paly, Evelyne ^b   Marche, Patrice N ^c   London, Jacqueline ^b  

^a CePo Centre Pluridisciplinaire d'Oncology   (Switzerland)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CEA GRENOBLE   (France)

Author keywords

Cu Zn superoxide dismutase; Down syndrome; Free radicals; Lymph nodes; Reactive oxygen species; Spleen; T lymphocytes; Thymus; Transgenic

Indexed keywords

BROXURIDINE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; LIPOCORTIN 5; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOWN SYNDROME; FLOW CYTOMETRY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; THYMUS;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DOWN SYNDROME; HUMANS; LONGITUDINAL STUDIES; MICE; MICE, TRANSGENIC; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES; THYMUS GLAND;

MUS MUSCULUS;

EID: 33646568473     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.01.029     Document Type: Article

References (61)

1. De La Torre R., Casado A., Lopez-Fernandez E., Carrascosa D., Ramirez V., and Saez J. Overexpression of copper-zinc superoxide dismutase in trisomy 21. Experientia 52 (1996) 871-873
2. Sinet P.M., Lavelle F., Michelson A.M., and Jerome H. Superoxide dismutase activities of blood platelets in trisomy 21. Biochem. Biophys. Res. Commun. 67 (1975) 904-909
3. Cossarizza A., Monti D., Montagnani G., Ortolani C., Masi M., Zannotti M., and Franceschi C. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am. J. Med. Genet. Suppl. 7 (1990) 213-218
4. Nespoli L., Burgio G.R., Ugazio A.G., and Maccario R. Immunological features of Down's syndrome: a review. J. Intellect. Disabil. Res. 37 Pt 6 (1993) 543-551
5. Noble R.L., and Warren R.P. Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21). Immunol. Invest. 16 (1987) 371-382
6. Prada N., Nasi M., Troiano L., Roat E., Pinti M., Nemes E., Lugli E., Ferraresi R., Ciacci L., Bertoni D., Biagioni O., Gibertoni M., Cornia C., Meschiari L., Gramazio E., Mariotti M., Consolo U., Balli F., and Cossarizza A. Direct analysis of thymic function in children with Down's syndrome. Immun. Ageing 2 (2005) 4
7. Cossarizza A., Ortolani C., Forti E., Montagnani G., Paganelli R., Zannotti M., Marini M., Monti D., and Franceschi C. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood 77 (1991) 1263-1270
8. Park E., Alberti J., Mehta P., Dalton A., Sersen E., and Schuller-Levis G. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin. Immunol. 95 (2000) 62-69
9. Fonseca E.C., Lannes-Vieira J., Villa-Verde D.M., and Savino W. Thymic extracellular matrix in Down's syndrome. Braz. J. Med. Biol. Res. 22 (1989) 971-974
10. Larocca L.M., Piantelli M., Valitutti S., Castellino F., Maggiano N., and Musiani P. Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). Clin. Immunol. Immunopathol. 49 (1988) 175-186
11. Murphy M., Insoft R.M., Pike-Nobile L., and Epstein L.B. A hypothesis to explain the immune defects in Down syndrome. Prog. Clin. Biol. Res. 393 (1995) 147-167
12. Musiani P., Valitutti S., Castellino F., Larocca L.M., Maggiano N., and Piantelli M. Intrathymic deficient expansion of T cell precursors in Down syndrome. Am. J. Med. Genet. Suppl. 7 (1990) 219-224
13. Aspinall R. Longevity and the immune response. Biogerontology 1 (2000) 273-278
14. Bar-Dayan Y., Afek A., Goldberg I., and Kopolovic J. Proliferation, apoptosis and thymic involution. Tissue Cell 31 (1999) 391-396
15. Li L., Hsu H.C., Grizzle W.E., Stockard C.R., Ho K.J., Lott P., Yang P.A., Zhang H.G., and Mountz J.D. Cellular mechanism of thymic involution. Scand. J. Immunol. 57 (2003) 410-422
16. Mackall C.L., and Gress R.E. Thymic aging and T-cell regeneration. Immunol. Rev. 160 (1997) 91-102
17. Turke P.W. Thymic involution. Immunol. Today 18 (1997) 407
18. Sun Q.L., Charyulu V., Lobo D., and Lopez D.M. Role of thymic stromal cell dysfunction in the thymic involution of mammary tumor-bearing mice. Anticancer Res. 22 (2002) 91-96
19. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., and Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 84 (1987) 8044-8048
20. Nabarra B., Casanova M., Paris D., Nicole A., Toyama K., Sinet P.M., Ceballos I., and London J. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21). Lab. Invest. 74 (1996) 617-626
21. Nabarra B., Casanova M., Paris D., Paly E., Toyoma K., Ceballos I., and London J. Premature thymic involution, observed at the ultrastructural level, in two lineages of human-SOD-1 transgenic mice. Mech. Ageing Dev. 96 (1997) 59-73
22. Peled-Kamar M., Lotem J., Okon E., Sachs L., and Groner Y. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome. EMBO J. 14 (1995) 4985-4993
23. Paz-Miguel J.E., Flores R., Sanchez-Velasco P., Ocejo-Vinyals G., Escribano de Diego J., Lopez de Rego J., and Leyva-Cobian F. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome. J. Immunol. 163 (1999) 5399-5410
24. Michie A.M., and Zuniga-Pflucker J.C. Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin. Immunol. 14 (2002) 311-323
25. Sebzda E., Mariathasan S., Ohteki T., Jones R., Bachmann M.F., and Ohashi P.S. Selection of the T cell repertoire. Annu. Rev. Immunol. 17 (1999) 829-874
26. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J. Immunol. 158 (1997) 3037-3045
27. Germeraad W.T., Kawamoto H., Itoi M., Jiang Y., Amagai T., Katsura Y., and van Ewijk W. Development of thymic microenvironments in vitro is oxygen-dependent and requires permanent presence of T-cell progenitors. J. Histochem. Cytochem. 51 (2003) 1225-1235
28. Prockop S.E., and Petrie H.T. Regulation of thymus size by competition for stromal niches among early T cell progenitors. J. Immunol. 173 (2004) 1604-1611
29. Thoman M.L. Early steps in T cell development are affected by aging. Cell. Immunol. 178 (1997) 117-123
30. Germain R.N. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2 (2002) 309-322
31. + stage are highly correlated in individual thymocytes. J. Exp. Med. 178 (1993) 1867-1875
32. Merkenschlager M., and Fisher A.G. T cell development: new approaches. Leukemia 7 Suppl. 2 (1993) S40-S44
33. Feng C., Woodside K.J., Vance B.A., El-Khoury D., Canelles M., Lee J., Gress R., Fowlkes B.J., Shores E.W., and Love P.E. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14 (2002) 535-544
34. Hare K.J., Jenkinson E.J., and Anderson G. CD69 expression discriminates MHC-dependent and-independent stages of thymocyte positive selection. J. Immunol. 162 (1999) 3978-3983
35. Pavlicek J., Sopko B., Ettrich R., Kopecky Jr. V., Baumruk V., Man P., Havlicek V., Vrbacky M., Martinkova L., Kren V., Pospisil M., and Bezouska K. Molecular characterization of binding of calcium and carbohydrates by an early activation antigen of lymphocytes CD69. Biochemistry 42 (2003) 9295-9306
36. Marklund S., and Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47 (1974) 469-474
37. Medvedev N., and Popova E.D. Thymus morphology in Down's syndrome. Arkh. Patol. 44 (1982) 27-30
38. Cimini V., Ruggiero G., Buonomo T., Seru R., Sciorio S., Zanzi C., Santangelo F., and Mondola P. CuZn-superoxide dismutase in human thymus: immunocytochemical localisation and secretion in thymus-derived epithelial and fibroblast cell lines. Histochem. Cell. Biol. 118 (2002) 163-169
39. Aronson M. Hypothesis: involution of the thymus with aging-Programmed and beneficial. Thymus 18 (1991) 7-13
40. Hirokawa K., Utsuyama M., Kasai M., Kurashima C., Ishijima S., and Zeng Y.X. Understanding the mechanism of the age-change of thymic function to promote T cell differentiation. Immunol. Lett. 40 (1994) 269-277
41. Adkins B., Charyulu V., Sun Q.L., Lobo D., and Lopez D.M. Early block in maturation is associated with thymic involution in mammary tumor-bearing mice. J. Immunol. 164 (2000) 5635-5640
42. Berzins S.P., Godfrey D.I., Miller J.F., and Boyd R.L. A central role for thymic emigrants in peripheral T cell homeostasis. Proc. Natl. Acad. Sci. USA 96 (1999) 9787-9791
43. Dunon D., Courtois D., Vainio O., Six A., Chen C.H., Cooper M.D., Dangy J.P., and Imhof B.A. Ontogeny of the immune system: gamma/delta and alpha/beta T cells migrate from thymus to the periphery in alternating waves. J. Exp. Med. 186 (1997) 977-988
44. - thymocytes and its implication in the late stage of thymocyte development. Immunology 97 (1999) 665-671
45. Pahlavani M.A., Mele J.F., and Richardson A. Effect of overexpression of human Cu/Zn-SOD on activation-induced lymphocyte proliferation and apoptosis. Free Radic. Biol. Med. 30 (2001) 1319-1327
46. Fiorini E., Schmitz I., Marissen W.E., Osborn S.L., Touma M., Sasada T., Reche P.A., Tibaldi E.V., Hussey R.E., Kruisbeek A.M., Reinherz E.L., and Clayton L.K. Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor. Mol. Cell 9 (2002) 637-648
47. + thymocytes reveals a T cell receptor-dependent proofreading mechanism controlling the completion of positive selection. J. Exp. Med. 197 (2003) 363-373
48. Mora A.L., Stanley S., Armistead W., Chan A.C., and Boothby M. Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB/Rel. J. Immunol. 167 (2001) 5628-5635
49. Huang C.Y., Fujimura M., Noshita N., Chang Y.Y., and Chan P.H. SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 21 (2001) 163-173
50. Casciati A., Ferri A., Cozzolino M., Celsi F., Nencini M., Rotilio G., and Carri M.T. Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J. Neurochem. 83 (2002) 1019-1029
51. Grisham M.B. Reactive oxygen species in immune responses. Free Radic. Biol. Med. 36 (2004) 1479-1480
52. Hildeman D.A. Regulation of T-cell apoptosis by reactive oxygen species. Free Radic. Biol. Med. 36 (2004) 1496-1504
53. Hildeman D.A., Mitchell T., Teague T.K., Henson P., Day B.J., Kappler J., and Marrack P.C. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10 (1999) 735-744
54. Borg J., and London J. Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J. Neurosci. Res. 70 (2002) 180-189
55. Chen Y., Chan P.H., and Swanson R.A. Astrocytes overexpressing Cu,Zn superoxide dismutase have increased resistance to oxidative injury. Glia 33 (2001) 343-347
56. Saito A., Hayashi T., Okuno S., Ferrand-Drake M., and Chan P.H. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. J. Neurosci. 23 (2003) 1710-1718
57. Fullerton H.J., Ditelberg J.S., Chen S.F., Sarco D.P., Chan P.H., Epstein C.J., and Ferriero D.M. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann. Neurol. 44 (1998) 357-364
58. Ying W., Anderson C.M., Chen Y., Stein B.A., Fahlman C.S., Copin J.C., Chan P.H., and Swanson R.A. Differing effects of copper,zinc superoxide dismutase overexpression on neurotoxicity elicited by nitric oxide, reactive oxygen species, and excitotoxins. J. Cereb. Blood Flow Metab. 20 (2000) 359-368
59. Xing J., Yu Y., and Rando T.A. The modulation of cellular susceptibility to oxidative stress: protective and destructive actions of Cu, Zn-superoxide dismutase. Neurobiol. Dis. 10 (2002) 234-246
60. Ewart J.L., and Auerbach R. Defects in thymocyte differentiation and thymocyte-stromal interactions in the trisomy 16 mouse. Dev. Immunol. 2 (1992) 215-226
61. Giannone S., Strippoli P., Vitale L., Casadei R., Canaider S., Lenzi L., D'Addabbo P., Frabetti F., Facchin F., Farina A., Carinci P., and Zannotti M. Gene expression profile analysis in human T lymphocytes from patients with Down syndrome. Ann. Hum. Genet. 68 (2004) 546-554